News about the Enterprise's Stakeholders.

Request for Concept Proposals - Creative and Novel Ideas in HIV Research Program for Early Career Investigators - December 2, 2009

The International AIDS Society in collaboration with the Centers for AIDS Research Program, U.S. National Institutes of Health, request concept proposals for a research grant program for early career investigators with no prior experience in HIV research. Please click the below link to learn more about the Creative and Novel Ideas in Research Awards Program.

Celebrating the Possible in the Fight Against AIDS - Mitchell Warren Editorial - November 30, 2009

Mitchell Warren, Executive Director of AVAC, wrote a piece for the Huffington Post calling for the celebration of the possibility of an AIDS vaccine. Please click here to read the piece

Phase I Study of Preventive HIV Vaccine Shows Improved Immune Responses When the Vaccine is Delivered by Electrical Impulses - November 30, 2009

A Phase 1 study of a preventive HIV vaccine show that a novel delivery mechanism known as electroporation helped to enhance the immunogenicity of the vaccine tested. Results were presented at the end of October at the AIDS Vaccine Conference in Paris, France. Please see the IAVI and Ichor Medical Systems, Inc. announcement below for more information.

AVAC Announces New Web Site For Comprehensive Coverage of Biomedical HIV Prevention Research - November 12, 2009

Visit the new AVAC web site: The site contains AVAC’s comprehensive coverage of the full range of biomedical HIV prevention interventions in an easy-to-use format that is searchable by intervention and by topic like policy, ethics and community involvement in research.

Collaboration for AIDS Vaccine Discovery Recognizes Adel Benlahrech and Yufei Wang for their Contributions to HIV Vaccine Research - October 30, 2009

To support the Global HIV Vaccine Enterprise’s efforts to raise the visibility and participation in the HIV vaccine field of Young and Early Career Investigators, the CAVD recognizes the young or early career investigators who have made significant contributions to research conducted within the CAVD. For more information, please click here.

Two Leading Research Institutions Partner to Accelerate the Development of an AIDS Vaccine Candidate - October 16, 2009

The International AIDS Vaccine Initiative (IAVI) announced today that it has signed a memorandum of understanding with the Ragon Institute to accelerate the development of new and promising AIDS vaccine candidates for testing

Wellcome Trust and Merck Launch First of its Kind Joint Venture to Develop Affordable Vaccines for Low-Income Countries - September 17, 2009

MSD Wellcome Trust Hilleman Laboratories is a first of its kind research and development joint venture with a not-for-profit mission focusing on developing affordable vaccines to prevent diseases that commonly affect low-income countries. For more information, please see the press release below.

Two New Antibodies Found to Cripple HIV - September 3, 2009

Researchers at and associated with the International AIDS Vaccine Initiative (IAVI), at The Scripps Research Institute, and at the biotechnology companies Theraclone Sciences and Monogram Biosciences have discovered two powerful new antibodies to HIV that reveal what may be an Achilles heel on the virus.

Syndicate content
Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account